conolidine - An Overview
These final results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the principle of targeting ACKR3 as a singular way to modulate the opioid program, which could open new therapeutic avenues for opioid-connected disorders.Distributing this evaluation implies